Peste des petits ruminants (PPR), also known as “small ruminant plague” or “Kata,” is a highly infectious and economically significant transboundary animal disease (TAD) affecting sheep and goats. The World Organization for Animal Health has listed it as a notifiable terrestrial animal disease
(Oie 2012). Small ruminant morbilli virus (SRMV), also known as PPR virus, is a member of the genus
Morbillivirus, which belongs to the family
Paramyxoviridae (http://ictvonline.org/virusTaxonomy.asp)
(Gibbs et al., 1979). The PPRV genome is made up of six transcriptional units that code for six proteins: 3’ N (Nucleocapsid protein), P (Phosphoprotein), M (Matrix protein), F (Fusion protein), H (Haemagglutinin) and L (Large protein) 5'
(Diallo, 1990).
Among the structural proteins of PPRV, N protein is the most antigenically conserved among morbilli viruses and, considering its internal position, is highly immunogenic
(Choi et al., 2005, Libeau et al., 1995). In morbilli virus-infected cells, the N protein is expressed at a very high level
(Diallo et al., 1990).
Morbilliviruses have four distinct regions in their N protein, conserved regions I (aa 1-120) and III (aa 146-420), as well as variable regions II (aa 121-145) and IV (aa 421-525).
(Munir et al., 2013). The C-terminal region of PPRV N (aa 454-472) were found to be highly selective for the virus.
(Dechamma et al., 2006). The H and F, two surface glycoproteins, either together or separately, induce neutralising and defensive antibody synthesis in the host
(Libeau, 2015 and
Liu et al., 2014). B cell epitope (BCE) regions of H protein have neutralizing antibody binding capacities from 263 to 368 aa and 538 to 609 aa
(Renukaradhya et al., 2002).
The identification of PPRV N
(Yu et al., 2015) and H
(Yu et al., 2017) BCEs shows the antigenic properties of the N and H proteins, laying the groundwork for developing epitope-based diagnostic assays for PPRV infections.
The viral neutralization test (VNT), competitive ELISA (C-ELISA) and indirect ELISA are the antibody detection tests used in the diagnosis of PPR. VNT is difficult to perform for routine sero-surveillance or sero-monitoring due to the need for cell culture facilities and sterile serum, particularly when a large number of samples need to be screened
(Singh et al., 2004).
Competitive ELISA was developed for the detection of antibodies to PPRV using a monoclonal antibody to a neutralizing epitope of H protein. The efficacy of c-ELISA compared favourably to VNT, with high specificity (98.4%) and sensitivity (95.4%) and it can replace the viral neutralization test
(Singh et al., 2004). Indirect ELISA, on the other hand, may be a good substitute for the time consuming and technically demanding viral neutralization test (VNT) and expensive competitive ELISA. When compared to cELISA, the indirect ELISA had a relative diagnostic specificity of 95.09 percent and a sensitivity of 90.81 per cent for PPR antibody detection
(Balamurugan et al., 2007).
The peptide based immunoassays are being developed as DIVA assays for several viruses
(Shen et al., 1999). Peptide ELISA for influenza subtypes showed promising results compared to HI, Immunofluorescence assay and immune-dot blot assay which had high cross reactivity
(Velumani et al., 2011). Peptide ELISA was also found to be a good choice for the detection of antibodies against Infectious bronchitis virus (IBV) and the evaluation of IBV vaccines when compared to immunofluorescence assay
(Yin et al., 2021). Peptide ELISA was also employed for detecting the immunogenicity and immunoreactivity of the protein compared to whole virus protein (WVP) based ELISA for Newcastle disease and it showed a positive correlation with HI.
(Ramani Pushpa et al., 2012). Synthetic peptide based competitive ELISA was also developed for PPR antibody detection
(Shrivastava, 2006). However, it has not been validated for diagnostic use with field samples. An epitope based competitive ELISA was developed by using hyperimmune serum prepared against epitope peptides of N protein of PPRV. In this assay recombinant N protein was used as the coating antigen. The sensitivity and specificity of the assay were 96.18 and 91.29%, respectively, in comparison to commercial cELISA kit
(Zhang et al., 2013).
In this study, we developed ELISA for PPRV antibody detection by employing PPRV N and H peptides and compared them with cELISA.